This inventor holds 2 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignee: Galderma S.a.. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Colette Pernin: Innovator in Dermatological Compositions
Introduction
Colette Pernin is a notable inventor based in Nice, France. She has made significant contributions to the field of dermatology through her innovative research and development of pharmaceutical compositions. With a total of 2 patents, her work focuses on treatments for skin disorders, particularly rosacea.
Latest Patents
Colette Pernin's latest patents include compositions comprising avermectin and azelaic acid compounds that are useful for treating conditions such as rosacea. These pharmaceutical and dermatological compositions contain effective amounts of at least one avermectin compound, such as ivermectin, and at least one azelaic acid compound or its salt or derivative. These formulations are designed to be physiologically acceptable for patients, ensuring safety and efficacy in treatment.
Career Highlights
Colette is currently associated with Galderma S.A., a company renowned for its focus on dermatological products. Her work at Galderma has allowed her to contribute to the development of innovative solutions for skin health, enhancing the quality of life for many individuals suffering from skin disorders.
Collaborations
Colette Pernin collaborates with her coworker, Alexandre Kaoukhov, to further advance their research and development efforts in dermatology. Their partnership exemplifies the importance of teamwork in driving innovation in the pharmaceutical industry.
Conclusion
Colette Pernin's contributions to dermatological compositions highlight her role as a key innovator in the field. Her patents and work at Galderma demonstrate her commitment to improving skin health through effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
